Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

Quotient Limited (NASDAQ: QTNT) announced its presentation at the Jefferies Virtual Healthcare Conference on June 2, 2020, at 9:00 a.m. ET. A webcast of the presentation will be available on the investor relations page of the Company's website and archived for approximately 90 days.

Quotient, a commercial-stage diagnostics company with 30 years of experience in transfusion diagnostics, is known for its MosaiQ technology. This innovative platform offers fully automated testing, enhancing efficiency and cost-effectiveness in laboratories worldwide.

JERSEY, Channel Islands, May 26, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the Company will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 9:00 a.m. ET.

A webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.quotientbd.com. A webcast replay will be archived on the website for approximately 90 days.

About Quotient Limited

Building on 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced. MosaiQ, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ platform is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. Quotient's operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

Contacts:

Peter Buhler, Chief Financial Officer, peter.buhler@quotientbd.com; +41 22 545 52 26

FAQ

What is Quotient Limited presenting at the Jefferies Virtual Healthcare Conference on June 2, 2020?

Quotient Limited will present its innovations and advancements in diagnostics technology at the Jefferies Virtual Healthcare Conference.

How can I access the webcast for Quotient Limited's presentation at the Jefferies Conference?

The webcast for Quotient Limited's presentation can be accessed through the investor relations page on their corporate website.

What is MosaiQ technology from Quotient Limited?

MosaiQ is Quotient Limited's proprietary multiplex microarray technology designed for fully automated testing across multiple diagnostic modalities.

Where are Quotient Limited's operations based?

Quotient Limited operates in Eysins, Switzerland, Edinburgh, Scotland, and Newtown, Pennsylvania.

What are the benefits of the MosaiQ platform according to Quotient Limited?

The MosaiQ platform is designed to improve clinical practice, enhance efficiencies, and deliver operational cost savings to laboratories globally.